Parkhurst et al. have recently reported less functional circulating NK cells, with lower expression of NKG2D and CD16 in melanoma and renal cell carcinoma patients post autologous NK cell infusion [34]. The gene discussed is KLRK1; the disease is hereditary clear cell renal cell carcinoma.